General information

In controlled studies, oxaprozin caused adverse effects in 23–58% of patients [ ]. It was considered better than aspirin and similar to other NSAIDs in long-term studies [ ]. However, treatment had to be interrupted owing to adverse effects in 8–31% of patients.

Organs and systems

Nervous system

Headache, dizziness, vertigo, and tinnitus are less frequent with oxaprozin than with indometacin or aspirin [ , ].

Metabolism

Drug-induced pseudoporphyria has been ascribed to oxaprozin [ ].

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here